Acamprosate in Relapse Prevention of Alcoholism

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Springer Berlin Heidelberg

• Publication date

  2011-12-08

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/978-3-642-80193-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence.

  1996cited by this paper
• The anti-craving drug acamprosate reduces c-fos expression in rats undergoing ethanol withdrawal.

  1996cited by this paper
• Acamprosate in the Treatment of Alcohol Dependence: A 6-Month Postdetoxification Study

  1996cited by this paper
• Acamprosate in alcohol dependence: how does it work?

  1995cited by this paper
• Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.

  1995cited by this paper
• The glutamatergic basis of human alcoholism.

  1995cited by this paper
• Antisocial tendencies and cortical sensory-evoked responses in alcoholism.

  1995cited by this paper
• Immediate-early gene activation as a window on mechanism in the nervous system

  1995cited by this paper
• Sensory cortical processing and the biological basis of personality.

  1995cited by this paper
• Localization of ERP generators and identification of underlying neural processes.

  1995cited by this paper
• Cognitive event-related potentials in human and non-human primates: implications for the PCP/NMDA model of schizophrenia.

  1995cited by this paper
• Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.

  1995cited by this paper
• Glutamate receptor update.

  1994influential reference
• Role of GABAA receptors in the actions of alcohol and in alcoholism: recent advances.

  1994cited by this paper
• Acute ethanol increases taurine in the nucleus accumbens but not glutamate nor GABA: microdialysis study

  1994cited by this paper
• Intensity dependence of auditory evoked dipole source activity.

  1994cited by this paper
• Changing subunit composition of heteromeric NMDA receptors during development of rat cortex

  1994cited by this paper
• A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence.

  1994cited by this paper
• Clinical Evaluation of Psychotropic Drugs: Principles and Guidelines

  1994cited by this paper
• Event-related potential amplitude/intensity slopes predict response to antidepressants.

  1994cited by this paper
• Naltrexone in the treatment of alcohol dependence.

  1994cited by this paper
• A Comparison of the Effects of Ethanol and the Competitive Glycine Antagonist 7‐Chlorokynurenic Acid on N‐Methyl‐d‐Aspartic Acid‐Induced Neurotransmitter Release from Rat Hippocampal Slices

  1994cited by this paper
• Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation.

  1994cited by this paper
• Binding characteristics of the calcium channel antagonist [3H]-nitrendipine in tissues from ethanol-dependent rats.

  1994cited by this paper
• Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms.

  1994cited by this paper
• The role of the NMDA receptor in ethanol withdrawal.

  1994cited by this paper
• Molecular biology of glutamate receptors. Potentiation of N-methyl-D-aspartate receptor splice variants by zinc.

  1994cited by this paper
• Evoked Potentials, Serotonin, and Suicidality

  1994cited by this paper
• Serotonin and alcohol intake, abuse, and dependence: clinical evidence.

  1994cited by this paper
• Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake.

  1994cited by this paper
• Effects of Acute and Chronic Ethanol Administration on the Poly-Phosphoinositide Signaling Activity in Brain

  1993cited by this paper
• GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol.

  1993cited by this paper
• Effects of in vitro ethanol and fetal ethanol exposure on glutathione stimulation of N-methyl-D-aspartate receptor function.

  1993cited by this paper
• Ethanol‐Induced Aspartate and Taurine Release from Primary Astrocyte Cultures

  1993cited by this paper
• Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro.

  1993cited by this paper
• Subunit‐specific block of cloned NMDA receptors by argiotoxin636

  1993cited by this paper
• Review and discussion of statistical analysis of controlled clinical trials in alcoholism.

  1993cited by this paper
• Taurine and ethanol-induced conditioned taste aversion.

  1993cited by this paper
• Inhibition of NMDA-evoked electrophysiological activity by ethanol in selected brain regions: evidence for ethanol-sensitive and ethanol-insensitive NMDA-evoked responses.

  1993cited by this paper
• Neuronal Ion Channels

  1993cited by this paper
• Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors.

  1993influential reference
• ACAMPROSAT : EIN STABILISIERUNGSFAKTOR IN DER LANGZEITENTWOHNUNG VON ALKOHOLABHANGIGEN

  1993cited by this paper
• [Acamprosate--a stabilizing factor in long-term withdrawal of alcoholic patients].

  1993cited by this paper
• Substitution by NMDA antagonists and other drugs in rats trained to discriminate ethanol

  1993cited by this paper
• Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.

  1993cited by this paper
• Blockade of chronic tolerance to ethanol by the NMDA antagonist, (+)-MK-801.

  1993cited by this paper
• Pharmacological approach of the treatment of drinking problems: a critical overview.

  1993cited by this paper
• Ethanol-induced suppression of hippocampal long-term potentiation is blocked by lesions of the septohippocampal nucleus.

  1993cited by this paper
• Densities of dopamine D2 receptors are reduced in CNS regions of alcohol-preferring P rats.

  1993cited by this paper
• Problems in the search for mechanisms of tolerance.

  1993influential reference
• Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis.

  1993cited by this paper
• Ethanol decreases glutamatergic synaptic transmission in rat nucleus accumbens in vitro: naloxone reversal.

  1993cited by this paper
• Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

  1993cited by this paper
• The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels.

  1993cited by this paper
• Chronic ethanol intoxication induces differential effects on GABAA and NMDA receptor function in the rat brain.

  1993cited by this paper
• Anesthetic Cutoff in Cycloalkanemethanols: A Test of Current Theories

  1993cited by this paper
• Pituitary responses to ca-acetyl homotaurinate in normal subjects and alcoholics

  1992cited by this paper
• Neurobiology of alcohol abuse.

  1992cited by this paper
• 5-HT and alcohol abuse.

  1992cited by this paper
• Excitatory amino acid neurotransmission, excitotoxicity and excitotoxins.

  1992cited by this paper
• Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats.

  1992cited by this paper
• Craving: consensus of status and agenda for future research.

  1992cited by this paper
• [Effect of acute administration of acamprosate on the risk of encephalopathy and on arterial pressure in patients with alcoholic cirrhosis].

  1992cited by this paper
• Microstructural analysis of the effects of THIP, a GABAA agonist, on voluntary ethanol intake in laboratory rats.

  1992cited by this paper
• Functional alterations in cerebral GABAA receptor complex associated with formation of alcohol dependence: analysis using GABA-dependent 36Cl- influx into neuronal membrane vesicles.

  1992cited by this paper
• The use of calcium carbimide in relapse prevention counselling: results of a randomized controlled trial.

  1992cited by this paper
• SEROTONERGIC AND DOPAMINERGIC INVOLVEMENT IN ETHANOL INTAKE

  1992cited by this paper
• Length of stay, patient severity and treatment outcome: sample data from the field of alcoholism.

  1992cited by this paper
• Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication: a replication study.

  1992cited by this paper
• GABA and Nucleus Accumbens Glutamate Neurotransmission Modulate Ethanol Self‐Administration in Rats a

  1992cited by this paper
• GABAergic involvement in the acquisition of voluntary ethanol intake in laboratory rats.

  1992cited by this paper
• Naltrexone and coping skills therapy for alcohol dependence. A controlled study.

  1992cited by this paper
• The Neurobiology of Drug and Alcohol Addiction

  1992cited by this paper
• Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing.

  1992cited by this paper
• Calcium-Acetylhomotaurinate for Maintaining Abstinence in Weaned Alcoholic Patients: A Placebo-Controlled Double-Blind Multicenter Study

  1992cited by this paper
• Intérêt d'aotal chez le malade alcoolique en pratique médicale courante : essair multicentrique sur 860 patients

  1992cited by this paper
• Calcium-diacetyl-homotaurinate which prevents relapse in weaned alcoholics decreases the action of excitatory amino acids in neocortical neurons of the rat in vitro

  1992cited by this paper
• Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals.

  1991cited by this paper
• Sites for antagonism on the N-methyl-D-aspartate receptor channel complex.

  1991cited by this paper
• Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.

  1991cited by this paper
• Serotonin uptake inhibitors: effects on motivated consummatory behaviors.

  1991cited by this paper
• Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour.

  1991cited by this paper
• Alcoholism Treatment: Context, Process, and Outcome

  1991cited by this paper
• Structural determinants of ion flow through recombinant glutamate receptor channels

  1991cited by this paper
• The Application of the Principle of Intention–to–Treat to the Analysis of Clinical Trials

  1991cited by this paper
• The Role of Calcium Flux in the Central Nervous System Actions of Ethanol

  1991cited by this paper
• Alcohol inhibition of NMDA channel function.

  1991cited by this paper
• Guide to clinical trials

  1991cited by this paper
• Pharmacotherapies for alcoholism: promising agents and clinical issues.

  1991cited by this paper
• The behavioral pharmacology of NMDA receptor antagonists.

  1990cited by this paper
• NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures.

  1990cited by this paper
• Patient characteristics and outcome of inpatient treatment for alcoholism.

  1990cited by this paper
• Calciumdiacetylhomotaurinate (CA-AOTA) decreases the action of excitatory amino acids in the rat neocortex in vitro.

  1990cited by this paper
• Ethanol Inhibition of N‐Methyl‐D‐Aspartate‐Stimulated Endogenous Dopamine Release from Rat Striatal Slices: Reversal by Glycine

  1990cited by this paper
• Are GABAB receptors involved in the pharmacological effects of ethanol?

  1990cited by this paper
• MK-801 impedes the acquisition of a spatial memory task in rats.

  1990cited by this paper
• Buspirone in the treatment of alcoholic patients.

  1989cited by this paper
• Dextromethorphan and neuromodulation: old drug coughs up new activities.

  1989cited by this paper
• Reinforcing and discriminative stimulus effects of Ca-acetyl homotaurine in animals.

  1989cited by this paper
• Psychopharmaka und kortikale evozierte Potentiale

  1989cited by this paper

• Predictive factors of long-term follow-up in treatment of Korean alcoholics with naltrexone or acamprosate

  2020cites this paper
• Treatment for Opioid Dependence

  2016cites this paper
• TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice

  2016cites this paper
• Advances in Electrophysiological Research

  2015cites this paper
• The development of acamprosate as a treatment against alcohol relapse

  2014cites this paper
• Acamprosat und Naltrexon als Kombinationstherapie bei Alkoholund Benzodiazepinabhängigkeit

  2013cites this paper
• Bağimlilik Psikofarmakolojisi Psychopharmacology of Addiction

  2012cites this paper
• Umgang mit alkoholisierten Patienten – Alkoholabhängigkeit

  2011cites this paper
• Pharmacotherapy for Alcoholism and Some Related Psychiatric and Addictive Disorders: Scientific Basis and Clinical Findings

  2010cites this paper
• Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model.

  2010cites this paper
• The Cost Effectiveness of Naltrexone Added to Cognitive-Behavioral Therapy in the Treatment of Alcohol Dependence

  2009cites this paper
• Incorporating Alcohol Pharmacotherapies Into Medical Practice : A Review of the Literature — Updates * A Treatment Improvement Protocol TIP 49

  2009cites this paper
• Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

  2008cites this paper
• Outcome of Alcohol Dependence Syndrome Cases Managed in Armed Forces.

  2008cites this paper
• Medikamente zur Behandlung von Abhängigkeit und Entzugssymptomen

  2008cites this paper
• Alkoholbedingte Störungen - Ätiopathogenese und therapeutischer Ausblick

  2007cites this paper
• Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.

  2007cites this paper
• Social Factors but Not Stress-Coping Styles Predict Relapse in Detoxified Alcoholics

  2007cites this paper
• What works in alcohol use disorders

  2006influential citation
• Pharmacotherapeutic Interventions to Maintaining Abstinence in Alcoholism

  2006cites this paper
• Acamprosate: a new tool in the battle against alcohol dependence

  2006cites this paper
• Review: acamprosate and naltrexone are safe and effective but have low compliance rates for people with alcohol dependence

  2005cites this paper
• Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials.

  2005influential citation
• Radioligands for Brain Imaging of the κ-Opioid System

  2005cites this paper
• Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients

  2005cites this paper
• Disulfiram (Antabuse®): the first medication to stop drinking

  2005cites this paper
• Pharmacotherapy in dual diagnosis

  2004cites this paper
• Biphasic effect of acamprosate on NMDA but not on GABAA receptors in spontaneous rhythmic activity from the isolated neonatal rat respiratory network.

  2004cites this paper
• No deterioration of cognitive performance in an aggressive unilateral and bilateral antidepressant rTMS add-on trial.

  2004cites this paper
• Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol.

  2004cites this paper
• OF SUBSTANCE USE DISORDERS THE SYSTEMATIC REVIEWS OF THE COCHRANE DRUGS AND ALCOHOL GROUP ( CDAG )

  2004cites this paper
• Homogenizing alcoholism treatment across Europe.

  2003cites this paper
• Acamprosate does not induce a conditioned place preference and reveals no state-dependent effects in this paradigm.

  2003cites this paper
• Pharmacotherapy for alcohol dependence

  2003cites this paper
• Expert opinion

  2003cites this paper
• Corpus callosum and visual cortex of mice with deletion of the NMDA-NR1 receptor. II. Attenuation of prenatal alcohol exposure effects.

  2003cites this paper
• Use of Acamprosate and Different Kinds of Psychosocial Support in Relapse Prevention of Alcoholism

  2002cites this paper
• Relapse Prevention and Maintaining Abstinence in Older Adults with Alcohol-Use Disorders

  2002cites this paper
• Disposition of acamprosate in the rat: Influence of probenecid

  2002cites this paper
• The European Acamprosate Trials: Conclusions for Research and Therapy

  2001cites this paper
• Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.

  2001cites this paper
• Regulation of NMDA receptors by ethanol.

  2000cites this paper
• Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

  2000cites this paper
• Interaction of acamprosate with ethanol and spermine on NMDA receptors in primary cultured neurons.

  2000cites this paper
• From Cell Membrane to Nucleus : The Effects of Alcohol on Brain Neurons

  2000cites this paper
• Treatment for opioid dependence: quality and access.

  2000cites this paper
• Acamprosate decreases the hypermotility during repeated ethanol withdrawal.

  1999cites this paper
• Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS

  1999cites this paper
• Pharmacologic treatments for drug and alcohol dependence.

  1999cites this paper
• LONG-TERM MANAGEMENT OF ALCOHOLIC LIVER DISEASE

  1998cites this paper
• Verlangen nach Alkohol: Psychophysiologische Korrelate

  1998cites this paper
• Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats.

  1998cites this paper
• Management of Alcohol Dependence after Detoxification

  1998cites this paper
• Clinical Pharmacokinetics of Acamprosate

  1998cites this paper
• Glutamatergic Neurotransmission in Alcoholism

  1998cites this paper
• Psychopharmaka bei Alkoholabhängigkeit — Indikationen, Interaktionen und Wirksamkeit

  1997cites this paper
• Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes.

  1997cites this paper
• Relapse Prevention in Alcoholism

  1997cites this paper
• Dual Diagnosis in Patients with Schizophrenia

  1996cites this paper
• Treatment of Alcohol Dependence With Medications

  year unknowncites this paper